본문 바로가기
KERD
논문KCI 등재

Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류내과학

초록

Obesity, along with its comorbidities, has become a significant public health concern worldwide. Bariatric surgery is considered themost effective treatment modality; however, only 2% of patients with obesity undergo bariatric surgery. Endoscopic bariatric andmetabolic therapies (EBMTs) are emerging alternatives to traditional bariatric surgery for patients who are not eligible for or donot prefer surgical treatment. EBMTs are generally categorized as space-occupying, gastric restrictive, aspiration, and small boweltherapies. We aimed to review various non-balloon and non-gastroplasty devices with available clinical data and discuss the possiblemechanisms of action, efficacy, and safety profile of these EMBTs.

Abstract

Obesity, along with its comorbidities, has become a significant public health concern worldwide. Bariatric surgery is considered themost effective treatment modality; however, only 2% of patients with obesity undergo bariatric surgery. Endoscopic bariatric andmetabolic therapies (EBMTs) are emerging alternatives to traditional bariatric surgery for patients who are not eligible for or donot prefer surgical treatment. EBMTs are generally categorized as space-occupying, gastric restrictive, aspiration, and small boweltherapies. We aimed to review various non-balloon and non-gastroplasty devices with available clinical data and discuss the possiblemechanisms of action, efficacy, and safety profile of these EMBTs.

참고문헌 (39)

  1. Bray GA, "Management of obesity", Lancet, 387, pp.1947~1956 (2016)
  2. Prospective Studies Collaboration, "Body-mass index and cause-specific mortality in 900 000 adults : collaborative analyses of 57 prospective studies", Lancet, 373, pp.1083~1096 (2009)
  3. ASGE, "ASMBS Task Force on Endoscopic Bariatric Therapy", A pathway to endoscopic bariatric therapies, 2011, pp.74, 943~953
  4. "Gastrointestinal surgery for severe obesity", Consens Statement, 9, pp.1~20 (1991)
  5. Arterburn DE, "Benefits and risks of bariatric surgery in adults : a review", JAMA, 324, pp.879~887 (2020)
  6. de Moura DTH, "Endoscopic sleeve gastroplasty : from whence we came and where we are going", World J Gastrointest Endosc, 11, pp.322~328 (2019)
  7. Joon Hyun Cho, "The Clinical and Metabolic Effects of Intragastric Balloon on Morbid Obesity and Its Related Comorbidities", Clinical Endoscopy, 54(1), pp.9~16 (2021), 대한소화기내시경학회[DOI]
  8. Jin Young Yoon, "The Efficacy and Safety of Endoscopic Sleeve Gastroplasty as an Alternative to Laparoscopic Sleeve Gastrectomy", Clinical Endoscopy, 54(1), pp.17~24 (2021), 대한소화기내시경학회[DOI]
  9. "Summary of safety and effectiveness data (SSED)" (2016)[URL]
  10. Sullivan S, "Endoscopic bariatric and metabolic therapies : new and emerging technologies", Gastroenterology, 152, pp.1791~1801 (2017)
  11. Swei EC, "Aspiration therapy", Tech Vasc Interv Radiol, 23, pp.100659~ (2020)
  12. Sullivan S, "Aspiration therapy leads to weight loss in obese subjects : a pilot study", Gastroenterology, 145, pp.1245~1252 (2013)
  13. Thompson CC, "Percutaneous gastrostomy device for the treatment of class II and class III obesity : results of a randomized controlled trial", Am J Gastroenterol, 112, pp.447~457 (2017)
  14. Nyström M, "Aspiration therapy as a tool to treat obesity : 1-to 4-year results in a 201-patient multi-center post-market European registry study", Obes Surg, 28, pp.1860~1868 (2018)
  15. Pichamol Jirapinyo, "Effect of Aspiration Therapy on Obesity-Related Comorbidities: Systematic Review and Meta-Analysis", Clinical Endoscopy, 53(6), pp.686~697 (2020), 대한소화기내시경학회[DOI]
  16. Ruban A, "The EndoBarrier : duodenal-jejunal bypass liner for diabetes and weight loss", Gastroenterol Res Pract, 2018, pp.7823182~ (2018)
  17. de Moura EG, "Effects of duodenal-jejunal bypass liner(EndoBarrier®)on gastric emptying in obese and type 2 diabetic patients", Obes Surg, 25, pp.1618~1625 (2015)
  18. Gersin KS, "Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates", Gastrointest Endosc, 71, pp.976~982 (2010)
  19. Rodriguez L, "Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes", Diabetes Technol Ther, 11, pp.725~732 (2009)
  20. Tarnoff M, "Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery", Surg Endosc, 23, pp.650~656 (2009)
  21. Glaysher MA, "A randomised controlled trial of a duodenal-jejunal bypass sleeve device(EndoBarrier)compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus", BMJ Open, 7, pp.e018598~ (2017)
  22. Koehestanie P, "The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial", Ann Surg, 260, pp.984~992 (2014)
  23. Schouten R, "A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery", Ann Surg, 251, pp.236~243 (2010)
  24. Rohde U, "Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes : a systematic review and meta-analysis", Diabetes Obes Metab, 18, pp.300~305 (2016)
  25. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, "ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies", Gastrointest Endosc, 82, pp.425~438 (2015)
  26. van Rijn S, "Effect of the EndoBarrier device : a 4-year follow-up of a multicenter randomized clinical trial", Obes Surg, 29, pp.1117~1121 (2019)
  27. Quezada N, "Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years", Surg Endosc, 32, pp.260~267 (2018)
  28. Jirapinyo P, "Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity : a meta-analysis with secondary analysis on weight loss and hormonal changes", Diabetes Care, 41, pp.1106~1115 (2018)
  29. Roehlen N, "Duodenal-jejunal bypass liner(DJBL)improves cardiovascular risk biomarkers and predicted 4-year risk of major CV events in patients with type 2 diabetes and metabolic syndrome", Obes Surg, 30, pp.1200~1210 (2020)
  30. Betzel B, "Adverse events of the duodenal-jejunal bypass liner : a systematic review", Obes Surg, 28, pp.3669~3677 (2018)
  31. Betzel B, "Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner : a 198 patient cohort study", Surg Endosc, 31, pp.2881~2891 (2017)
  32. Sandler BJ, "Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve", Surg Endosc, 25, pp.3028~3033 (2011)
  33. Sandler BJ, "One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity", Surg Endosc, 29, pp.3298~3303 (2015)
  34. Cherrington AD, "Hydrothermal duodenal mucosal resurfacing : role in the treatment of metabolic disease", Gastrointest Endosc Clin N Am, 27, pp.299~311 (2017)
  35. Rajagopalan H, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes : 6-month interim analysis from the first-in-human proof-of-concept study", Diabetes Care, 39, pp.2254~2261 (2016)
  36. van Baar ACG, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus : one year results from the first international, open-label, prospective, multicentre study", Gut, 69, pp.295~303 (2020)
  37. Aithal G, "Endoscopic duodenal mucosal resurfacing improves hepatic fat fraction, glycemic and lipid profiles in type 2 diabetes", J Hepatol, 70(1 Suppl), pp.e70~e71 (2019)
  38. Ryou M, "Minimally invasive entero-enteral dual-path bypass using self-assembling magnets", Surg Endosc, 30, pp.4533~4538 (2016)
  39. Machytka E, "Partial jejunal diversion using an incisionless magnetic anastomosis system : 1-year interim results in patients with obesity and diabetes", Gastrointest Endosc, 86, pp.904~912 (2017)

관련 논문AI추천

이 간행물의 다른 논문 (22건)